Epigenetic regulation of lymphatic development
淋巴管发育的表观遗传调控
基本信息
- 批准号:10192805
- 负责人:
- 金额:$ 41.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcetylationAreaBloodChromatinChromatin Remodeling FactorChylothoraxComplexCongenital Cardiovascular AbnormalityCuesDNADNA Binding DomainDataDeacetylaseDeacetylationDevelopmentDiseaseDrainage procedureElementsEnhancersEnzymesEpigenetic ProcessExhibitsGenetic TranscriptionGoalsHistone AcetylationHistone DeacetylaseHistone DeacetylationHistone H3HistonesHumanLiquid substanceLymphatic Endothelial CellsLymphatic EndotheliumLymphedemaMAPK1 geneMediatingModelingMolecularMorbidity - disease rateMorphogenesisMusMutant Strains MiceMutateMutationNeonatalNoonan SyndromePTPN11 genePathologicPathologyPatientsPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesProteinsRas/RafResearchRoleSignal PathwaySignal TransductionStructureSyndromeTestingTissuesTranscriptional Activationbasecofactoreffective therapyepigenetic regulationepigenomeexperimental studyextracellulargain of functiongain of function mutationgene repressionhistone acetyltransferaseloss of functionlymphatic developmentlymphatic drainagelymphatic malformationslymphatic valvelymphatic vasculaturelymphatic vesselnovelprogramsrecruitresponseshear stresstranscription factor
项目摘要
Project Summary/Abstract:
Lymphedema is the most common lymphatic anomaly and it is responsible for considerable morbidity, with no
current effective treatments. Improper drainage of extravasated protein-rich fluid from the tissues causes it to
accumulate, resulting in lymphedema. This condition frequently involves defective lymphatic valve
development, yet the epigenetic modifiers underlying lymphatic-valve morphogenesis remain unknown. Two
opposing classes of histone-modifying enzymes, histone acetyltransferases (HATs) and histone deacetylases
(HDACs) regulate the acetylation state of histones. Acetylation by HATs is generally associated with
transcriptional activation while HDAC-mediated deacetylation usually results in transcriptional repression.
HDACs lack intrinsic DNA-binding domains but modify epigenome in a signal-dependent manner via their
interactions with chromatin modifiers, transcription factors, and cofactors. Our findings suggest a novel
chromatin dependent, but deacetylase-independent role of Hdac3 in murine lymphatic valve development. We
find that Hdac3 functions as an essential flow-responsive epigenetic switch to establish a specific
transcriptional program for lymphatic valve development. Our data challenge long-held assumptions that
HDACs replace HATs to promote both histone deacetylation and repression of transcription. The goal of this
research program is to identify how Hdac3 establishes and maintains a specific transcriptional program for
lymphatic valve development. In addition, proposed studies will identify the mechanisms by which different
transcription factors, kinases, and phosphatases involved in signaling pathways regulate the chromatin
recruitment, phosphorylation, and function of Hdac3 within developing lymphatic vasculature. Despite intense
study in the area of epigenetics, very little is known about the role of epigenetic and chromatin modifiers in the
field of lymphatic development. The set of experiments outlined in this proposal have broad significance not
only for understanding how signaling pathways intersect with chromatin modifiers to regulate lymphatic valve
development, but also could be highly applicable to the entire field of congenital cardiovascular diseases.
项目摘要/摘要:
淋巴水肿是最常见的淋巴异常,它导致相当大的发病率,但没有
目前有效的治疗方法。组织中外渗的富含蛋白质的液体不正确排出会导致其
积聚,导致淋巴水肿。这种情况通常涉及淋巴瓣膜缺陷
然而,淋巴瓣形态发生背后的表观遗传修饰因素仍然未知。二
相反类别的组蛋白修饰酶、组蛋白乙酰转移酶 (HAT) 和组蛋白脱乙酰酶
(HDAC) 调节组蛋白的乙酰化状态。 HAT 的乙酰化通常与
转录激活,而 HDAC 介导的去乙酰化通常会导致转录抑制。
HDAC 缺乏内在的 DNA 结合域,但通过其信号依赖性方式修改表观基因组。
与染色质修饰剂、转录因子和辅因子的相互作用。我们的发现表明了一部小说
Hdac3 在小鼠淋巴瓣发育中的染色质依赖但脱乙酰酶独立的作用。我们
发现 Hdac3 作为一个重要的流响应表观遗传开关来建立特定的
淋巴瓣发育的转录程序。我们的数据挑战了长期以来的假设:
HDAC 取代 HAT 促进组蛋白脱乙酰化和转录抑制。此举的目标
研究计划的目的是确定 Hdac3 如何建立和维护特定的转录程序
淋巴瓣发育。此外,拟议的研究将确定不同的机制
参与信号通路调节染色质的转录因子、激酶和磷酸酶
Hdac3 在发育中的淋巴管系统中的募集、磷酸化和功能。尽管激烈
在表观遗传学领域的研究中,人们对表观遗传学和染色质修饰剂在表观遗传学中的作用知之甚少。
淋巴管发育领域。该提案中概述的一组实验具有广泛的意义,但不
仅用于了解信号通路如何与染色质修饰剂相交叉来调节淋巴瓣膜
的发展,而且也可以高度适用于先天性心血管疾病的整个领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chinmay M Trivedi其他文献
Chinmay M Trivedi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chinmay M Trivedi', 18)}}的其他基金
Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
- 批准号:
9045696 - 财政年份:2013
- 资助金额:
$ 41.88万 - 项目类别:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
- 批准号:
8669159 - 财政年份:2013
- 资助金额:
$ 41.88万 - 项目类别:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
- 批准号:
10399458 - 财政年份:2013
- 资助金额:
$ 41.88万 - 项目类别:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
- 批准号:
8479285 - 财政年份:2013
- 资助金额:
$ 41.88万 - 项目类别:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
染色质修饰酶对心脏发育的调节
- 批准号:
9251882 - 财政年份:2013
- 资助金额:
$ 41.88万 - 项目类别:
Hdac2 and Hopx: Regulators of Cardiac Development
Hdac2 和 Hopx:心脏发育的调节因子
- 批准号:
8307117 - 财政年份:2011
- 资助金额:
$ 41.88万 - 项目类别:
Hdac2 and Hopx: Regulators of Cardiac Development
Hdac2 和 Hopx:心脏发育的调节因子
- 批准号:
8316199 - 财政年份:2011
- 资助金额:
$ 41.88万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Genetic and molecular mechanisms of Xbp-1 mediated salivary gland development and differentiation
Xbp-1介导唾液腺发育和分化的遗传和分子机制
- 批准号:
10678146 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Metabolic Control of Proliferation and Differentiation in Oligodendrocytes
少突胶质细胞增殖和分化的代谢控制
- 批准号:
10315354 - 财政年份:2021
- 资助金额:
$ 41.88万 - 项目类别:
Metabolic Control of Proliferation and Differentiation in Oligodendrocytes
少突胶质细胞增殖和分化的代谢控制
- 批准号:
10453440 - 财政年份:2021
- 资助金额:
$ 41.88万 - 项目类别:
Transcriptional Control of Microglia Diversification and Inflammation
小胶质细胞多样化和炎症的转录控制
- 批准号:
10590636 - 财政年份:2020
- 资助金额:
$ 41.88万 - 项目类别:
Transcriptional control of microglia diversification and inflammation
小胶质细胞多样化和炎症的转录控制
- 批准号:
10349504 - 财政年份:2020
- 资助金额:
$ 41.88万 - 项目类别: